Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 20689423)

1.

Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.

Kosek M, Yori PP, Olortegui MP.

Curr Opin Infect Dis. 2010 Oct;23(5):475-80. doi: 10.1097/QCO.0b013e32833da204. Review.

PMID:
20689423
2.

Shigellosis.

Niyogi SK.

J Microbiol. 2005 Apr;43(2):133-43. Review.

3.

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB.

Nat Rev Microbiol. 2007 Jul;5(7):540-53. Review.

4.

Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.

Niyogi SK.

Clin Microbiol Infect. 2007 Dec;13(12):1141-3. Epub 2007 Oct 22.

5.

Shigellosis: the current status of vaccine development.

Kweon MN.

Curr Opin Infect Dis. 2008 Jun;21(3):313-8. doi: 10.1097/QCO.0b013e3282f88b92. Review.

PMID:
18448978
6.

Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis.

Gaston JS, Inman RD, Ryan ET, Venkatesan MM, Barry EM, Hale TL, Bourgeois AL, Walker RI.

Vaccine. 2009 Sep 4;27(40):5432-4. doi: 10.1016/j.vaccine.2009.06.107. Epub 2009 Jul 28.

PMID:
19643213
7.

[Specific prophylaxis of shigellosis].

Bondarenko VM.

Zh Mikrobiol Epidemiol Immunobiol. 2003 Sep-Oct;(5):101-8. Review. Russian.

PMID:
14565136
8.

Bacterial enteric pathogens in children with acute dysentery in Thailand: increasing importance of quinolone-resistant Campylobacter.

Bodhidatta L, Vithayasai N, Eimpokalarp B, Pitarangsi C, Serichantalergs O, Isenbarger DW.

Southeast Asian J Trop Med Public Health. 2002 Dec;33(4):752-7.

PMID:
12757222
9.

Magnitude of drug resistant Shigellosis: a report from Bangalore.

Srinivasa H, Baijayanti M, Raksha Y.

Indian J Med Microbiol. 2009 Oct-Dec;27(4):358-60. doi: 10.4103/0255-0857.55460.

10.

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.

von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh do G, Chaicumpa W, Agtini MD, Hossain A, Bhutta ZA, Mason C, Sethabutr O, Talukder K, Nair GB, Deen JL, Kotloff K, Clemens J.

PLoS Med. 2006 Sep;3(9):e353.

11.

Response to antimicrobial therapy for shigellosis in Thailand.

Lolekha S, Vibulbandhitkit S, Poonyarit P.

Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S342-6. Review.

PMID:
2047660
12.

Shigella infections in children: new insights.

Ashkenazi S.

Semin Pediatr Infect Dis. 2004 Oct;15(4):246-52. Review.

PMID:
15494948
13.

Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique.

Mandomando I, Sigaúque B, Vallès X, Espasa M, Sanz S, Sacarlal J, Macete E, Abacassamo F, Ruiz J, Gascon J, Kotloff KL, Levine MM, Alonso PL.

Pediatr Infect Dis J. 2007 Nov;26(11):1059-61.

PMID:
17984817
14.

Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009.

Wong MR, Reddy V, Hanson H, Johnson KM, Tsoi B, Cokes C, Gallagher L, Lee L, Plentsova A, Dang T, Krueger A, Joyce K, Balter S.

Microb Drug Resist. 2010 Jun;16(2):155-61. doi: 10.1089/mdr.2009.0130.

PMID:
20438349
15.

A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan.

Soofi SB, Habib MA, von Seidlein L, Khan MJ, Muhammad S, Bhutto N, Khan MI, Rasool S, Zafar A, Clemens JD, Nizami Q, Bhutta ZA.

J Infect Public Health. 2011 Mar;4(1):12-21. doi: 10.1016/j.jiph.2010.10.001. Epub 2011 Feb 1.

PMID:
21338955
16.

Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study.

Nandy S, Mitra U, Rajendran K, Dutta P, Dutta S.

Trop Med Int Health. 2010 Dec;15(12):1499-507. doi: 10.1111/j.1365-3156.2010.02656.x. Epub 2010 Oct 18.

17.

[The role of antibiotic-resistance of Shigella in the epidemiology of dysentery (literature review)].

Popovich GG, Bondarenko VI.

Vrach Delo. 1983 Aug;(8):111-5. Review. Russian. No abstract available.

PMID:
6356591
18.

Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.

Iwalokun BA, Gbenle GO, Smith SI, Ogunledun A, Akinsinde KA, Omonigbehin EA.

J Health Popul Nutr. 2001 Sep;19(3):183-90.

PMID:
11761772
19.

Recent progress towards development of a Shigella vaccine.

Camacho AI, Irache JM, Gamazo C.

Expert Rev Vaccines. 2013 Jan;12(1):43-55. doi: 10.1586/erv.12.135. Review.

PMID:
23256738
20.

Inactivated and subunit vaccines to prevent shigellosis.

Kaminski RW, Oaks EV.

Expert Rev Vaccines. 2009 Dec;8(12):1693-704. doi: 10.1586/erv.09.127. Review.

PMID:
19943764
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk